{
    "organizations": [],
    "uuid": "6e43e45adfb57545573d3c092b017bb7ba2a418d",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-shandong-xinhua-pharmaceutical-upd/brief-shandong-xinhua-pharmaceutical-updates-on-resumption-of-trading-in-a-shares-idUSFWN1Q30RH",
    "ord_in_thread": 0,
    "title": "Shandong Xinhua Pharmaceutical Updates On Resumption Of Trading In A Shares",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 13 (Reuters) - Shandong Xinhua Pharmaceutical Co Ltd :\n* CO APPLIED FOR RESUMPTION OF TRADING IN A SHARES ON SZSE WITH EFFECT FROM 14 FEB\n* TRADING OF H SHARES OF COMPANY LISTED ON SEHK WILL NOT BE AFFECTED AND WILL CONTINUE Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-13T19:44:00.000+02:00",
    "crawled": "2018-02-14T12:16:35.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "shandong",
        "xinhua",
        "pharmaceutical",
        "co",
        "ltd",
        "co",
        "applied",
        "resumption",
        "trading",
        "share",
        "szse",
        "effect",
        "feb",
        "trading",
        "h",
        "share",
        "company",
        "listed",
        "sehk",
        "affected",
        "continue",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}